37000v威尼斯(中國股份)有限公司-官方網站歡迎您 /i-mab-biopharma-expands-strategic-collaboration-with-wuxi-biologics-and-licenses-wuxibody-platform-for-three-bispecific-antibody-programs/ 提供端到端一站式解决方案 Wed, 07 Sep 2022 13:19:08 +0000 hourly 1